News

Sponge on a string test to transform oesophageal cancer diagnosis

A ‘sponge on a string’ pill test can identify ten times more people with Barrett’s oesophagus than the usual GP route, according new research. Read more

New NHS service enables people to sign up to be contacted for COVID-19 vaccine studies

A new NHS service has been launched, helping people across the UK sign up for information on the new COVID-19 vaccine trials.Read more

New funding boost to speed up diagnosis in oesophageal cancer

Cambridge will lead on improving early detection in oesophageal cancer as part of a Government backed projectRead more

National research platform launches new website

The address is the same, but the next time you visit the NIHR BioResource website, you’ll see it has a brand new look, ready for researchers and the public.Read more

Phased re-start of non-COVID-19 research

In line with NIHR guidance, we are beginning the process of phased re-opening of some non-COVID-19 research studies, while maintaining our contribution to local and nationally prioritised urgent public health studies for COVID-19.Read more

Prestigious fellowship election for NIHR Cambridge BRC researchers

The NIHR Cambridge BRC is delighted that three of our researchers have been elected as Fellows of the Academy of Medical Sciences.Read more

POPStar study launches to investigate how pregnancy data can predict future health

A new study from the Departments of Obstetrics & Gynaecology and Paediatrics at the University of Cambridge is investigating how conditions in the womb can predict the future health of mothers and their children.Read more

Over 150 participants recruited to new COVID-19 research programme

A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.Read more

Cambridge trial targets immune response to treat COVID-19 patients

A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two drugs that are already in use to treat other immune-related conditions Read more

Genetic analysis reveals new causes of Primary Immunodeficiency (PID)

A UK-wide research collaboration through the National Institute for Health Research (NIHR) BioResource for Rare Diseases has combined whole genome sequencing (WGS) with a statistical program called BeviMed to predict the existence of disease-causing changes in the DNA of people with Primary Immunodeficiency (PID).  Read more

NIHR Cambridge BRC and CRF begin working on new COVID-19 study

Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a research trial into COVID-19.Read more

Fast-track HRA review of COVID-19 studies

The Health Research Authority (HRA) is working with the rest of the research system to provide a coordinated process so that COVID-19 research can progress quickly, using a fast-track review process with bespoke Read more

Discover more

If you would like more information about NIHR Cambridge BRC, please contact us.